Bharat Biotech says death of Bhopal volunteer not related to its coronavirus vaccine trials

The case comes amid concerns being raised by industry experts and opposition parties on the emergency approval granted to Bharat Biotech's coronavirus vaccine ‘Covaxin’ without publication of efficacy data. The Phase III clinical trials are underway.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3boTkHW
via IFTTT